Charnell I. Sommers

422 total citations
15 papers, 360 citations indexed

About

Charnell I. Sommers is a scholar working on Molecular Biology, Cancer Research and Ophthalmology. According to data from OpenAlex, Charnell I. Sommers has authored 15 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Cancer Research and 3 papers in Ophthalmology. Recurrent topics in Charnell I. Sommers's work include Protease and Inhibitor Mechanisms (5 papers), Corneal Surgery and Treatments (3 papers) and Bioactive Compounds and Antitumor Agents (2 papers). Charnell I. Sommers is often cited by papers focused on Protease and Inhibitor Mechanisms (5 papers), Corneal Surgery and Treatments (3 papers) and Bioactive Compounds and Antitumor Agents (2 papers). Charnell I. Sommers collaborates with scholars based in United States and China. Charnell I. Sommers's co-authors include Roswell R. Pfister, Jeffrey L. Haddox, Kwok‐Wai Lam, Matteo Villain, J. Edwin Blalock, G.M. Anantharamaiah, Manjula Chaddha, Donald D. Muccio, Wayne J. Brouillette and Lawrence J. DeLucas and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Immunological Methods and Biopolymers.

In The Last Decade

Charnell I. Sommers

15 papers receiving 332 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Charnell I. Sommers United States	13	108	90	73	70	66	15	360
Véronique Guyonnet Dupérat France	5	272 2.5×	45 0.5×	27 0.4×	38 0.5×	79 1.2×	5	339
Shoji Okamoto Japan	12	98 0.9×	77 0.9×	15 0.2×	33 0.5×	90 1.4×	33	381
Allen Nguyen United States	11	193 1.8×	58 0.6×	38 0.5×	50 0.7×	188 2.8×	22	504
Marie‐France Counis France	9	350 3.2×	20 0.2×	64 0.9×	44 0.6×	63 1.0×	11	437
P.K. Schork United States	4	110 1.0×	30 0.3×	15 0.2×	41 0.6×	70 1.1×	9	308
Zixuan Zheng China	14	195 1.8×	37 0.4×	64 0.9×	100 1.4×	61 0.9×	23	439
Rachel Seidman Israel	8	197 1.8×	71 0.8×	30 0.4×	199 2.8×	133 2.0×	8	445
Jane Berkelhammer United States	12	137 1.3×	33 0.4×	40 0.5×	168 2.4×	170 2.6×	23	426
Tom C. Tsang United States	15	287 2.7×	21 0.2×	43 0.6×	131 1.9×	95 1.4×	32	578

Countries citing papers authored by Charnell I. Sommers

Since Specialization

Citations

This map shows the geographic impact of Charnell I. Sommers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charnell I. Sommers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charnell I. Sommers more than expected).

Fields of papers citing papers by Charnell I. Sommers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charnell I. Sommers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charnell I. Sommers. The network helps show where Charnell I. Sommers may publish in the future.

Co-authorship network of co-authors of Charnell I. Sommers

This figure shows the co-authorship network connecting the top 25 collaborators of Charnell I. Sommers. A scholar is included among the top collaborators of Charnell I. Sommers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charnell I. Sommers. Charnell I. Sommers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Schormann, Norbert, Charnell I. Sommers, Mark N. Prichard, et al.. (2011). Identification of Protein-Protein Interaction Inhibitors Targeting Vaccinia Virus Processivity Factor for Development of Antiviral Agents. Antimicrobial Agents and Chemotherapy. 55(11). 5054–5062. 18 indexed citations

Li, Haibo, Xiangrong Zhang, Wei Wang, et al.. (2010). Development and validation of an HPLC method for quantitation of BA‐TPQ, a novel iminoquinone anticancer agent, and an initial pharmacokinetic study in mice. Biomedical Chromatography. 25(5). 628–634. 7 indexed citations

Li, Haibo, Hongxia Xu, Xiangrong Zhang, et al.. (2010). Preclinical Pharmacology of BA-TPQ, a Novel Synthetic Iminoquinone Anticancer Agent. Marine Drugs. 8(7). 2129–2141. 22 indexed citations

Pfister, Roswell R. & Charnell I. Sommers. (2006). L-Arginine-Threonine-Arginine (RTR) Tetramer Peptide Inhibits Ulceration in the Alkali-injured Rabbit Cornea. Cornea. 25(10). 1187–1192. 6 indexed citations

Pfister, Roswell R. & Charnell I. Sommers. (2005). Fibrin Sealant in Corneal Stem Cell Transplantation. Cornea. 24(5). 593–598. 37 indexed citations

Jackson, Patricia L., Michael J. Jablonsky, Donald D. Muccio, et al.. (2001). NMR conformational analysis ofcis andtrans proline isomers in the neutrophil chemoattractant, N-acetyl-proline-glycine-proline. Biopolymers. 58(6). 548–561. 13 indexed citations

Haddox, Jeffrey L., Roswell R. Pfister, Charnell I. Sommers, J. Edwin Blalock, & Matteo Villain. (2001). Inhibitory effect of a complementary peptide on ulceration in the alkali-injured rabbit cornea.. PubMed. 42(12). 2769–75. 20 indexed citations

Pfister, Roswell R., et al.. (2000). Synthetic Complementary Peptides Inhibit a Neutrophil Chemoattractant Found in the Alkali-injured Cornea. Cornea. 19(3). 384–389. 14 indexed citations

Haddox, Jeffrey L., Roswell R. Pfister, Donald D. Muccio, et al.. (1999). Bioactivity of peptide analogs of the neutrophil chemoattractant, N-acetyl-proline-glycine-proline.. PubMed. 40(10). 2427–9. 36 indexed citations

10.

Pfister, Roswell R., Jeffrey L. Haddox, & Charnell I. Sommers. (1998). Injection of chemoattractants into normal cornea: a model of inflammation after alkali injury.. PubMed. 39(9). 1744–50. 46 indexed citations

11.

Pfister, Roswell R., Jeffrey L. Haddox, & Charnell I. Sommers. (1997). Effect of synthetic metalloproteinase inhibitor or citrate on neutrophil chemotaxis and the respiratory burst.. PubMed. 38(7). 1340–9. 23 indexed citations

12.

Pfister, Roswell R., Jeffrey L. Haddox, Charnell I. Sommers, & Kwok‐Wai Lam. (1995). Identification and synthesis of chemotactic tripeptides from alkali-degraded whole cornea. A study of N-acetyl-proline-glycine-proline and N-methyl-proline-glycine-proline.. PubMed. 36(7). 1306–16. 61 indexed citations

13.

Haddox, Jeffrey L., Ian Knowles, Charnell I. Sommers, & Roswell R. Pfister. (1994). Characterization of chemical gradients in the collagen gel-visual chemotactic assay. Journal of Immunological Methods. 171(1). 1–14. 13 indexed citations

14.

Pfister, Roswell R., Jeffrey L. Haddox, & Charnell I. Sommers. (1993). Alkali-degraded cornea generates a low molecular weight chemoattractant for polymorphonuclear leukocytes.. PubMed. 34(7). 2297–304. 22 indexed citations

15.

Haddox, Jeffrey L., Roswell R. Pfister, & Charnell I. Sommers. (1991). A visual assay for quantitating neutrophil chemotaxis in a collagen gel matrix. Journal of Immunological Methods. 141(1). 41–52. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact